| 
 | |||||
|   | 
| 
 | 

Water analytics and treatment company Veralto (NYSE:VLTO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 6.8% year on year to $1.40 billion. On the other hand, next quarter’s revenue guidance of $1.38 billion was less impressive, coming in 1.4% below analysts’ estimates. Its non-GAAP profit of $0.99 per share was 4.6% above analysts’ consensus estimates.
Is now the time to buy VLTO? Find out in our full research report (it’s free for active Edge members).
Veralto’s third quarter results reflected steady execution across its core Water Quality and Product Quality and Innovation (PQI) segments, with management attributing growth to new customer wins and increased market penetration. CEO Jennifer Honeycutt highlighted the company’s ability to navigate a dynamic macro environment, noting that demand was broad-based across geographies and end markets. Management credited pricing actions, particularly in response to tariffs, and continued operational improvements for supporting margins. Honeycutt also pointed to the importance of the Veralto Enterprise System in helping deliver consistent results, emphasizing, “Our team delivered mid-single-digit core sales growth, double-digit adjusted earnings per share growth and over 100% free cash flow conversion.”
Looking ahead, management’s updated guidance is shaped by ongoing investments in strategic growth areas and disciplined capital deployment, even as near-term revenue expectations are slightly more cautious. CFO Sameer Ralhan acknowledged that tariff mitigation costs and ongoing growth investments will weigh on PQI margins in the near term, but expressed confidence that these headwinds will ease by the middle of next year. Honeycutt emphasized the opportunity in AI-driven infrastructure, stating, “We are well positioned to capitalize on the rapid growth of infrastructure required to support AI growth.” The company expects continued strength from recurring revenue streams, new product launches, and expansion into high-growth markets, while maintaining flexibility for targeted acquisitions.
Management attributed broad-based sales growth and stable margins to strategic pricing, new product traction, and disciplined cost controls, especially in the face of tariff pressures and evolving end markets.
Veralto’s forward guidance is influenced by ongoing tariff impacts, continued investment in growth areas, and the secular demand for water analytics and treatment solutions.
In the quarters ahead, the StockStory team will be closely watching (1) the pace of margin recovery in PQI as tariff mitigation actions take hold, (2) continued expansion in data center and AI-related water treatment projects within Water Quality, and (3) the integration and performance of recent acquisitions such as TraceGains. Additional milestones will include growth in recurring revenue streams and potential M&A activity leveraging Veralto’s strong balance sheet.
Veralto currently trades at $99.45, down from $102.54 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-26 | |
| Oct-21 | |
| Oct-17 | |
| Oct-16 | |
| Oct-10 | |
| Oct-09 | 
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite